查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1829882

2025年全球呼吸诊断设备市场报告

Respiratory Devices And Equipment (Diagnostic) Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，呼吸诊断设备市场呈现强劲成长势头，市场规模从2024年的78.1亿美元成长至2025年的83.6亿美元，复合年增长率为7.0%。预测期内的成长归因于慢性呼吸系统疾病、人口老化、吸烟、环境因素以及技术进步。

预计未来几年呼吸诊断市场将强劲成长，到2029年将达到121.3亿美元，复合年增长率为9.8%。预测期内的成长将受到呼吸道感染疾病、远端医疗和远端监控、个人化医疗以及人工智慧和机器学习的推动。预测期内的主要趋势包括肺功能测试 (PFT)、家庭呼吸监测、远端医疗整合以及戒烟辅助工具。

呼吸诊断设备和仪器用于诊断气喘、囊肿纤维化和慢性阻塞性肺病等呼吸系统疾病。这些设备可测量肺功能和血氧水平，帮助医疗保健提供者评估和管理呼吸系统健康状况。

呼吸诊断设备市场的关键产品包括仪器和设备，以及检测试剂和试剂。这些呼吸设备和设备对于诊断各种呼吸系统疾病至关重要。诊断测试种类繁多，包括传统诊断测试、机械测试、影像检查和分子诊断测试，所有这些测试都用于诊断慢性阻塞性肺病(COPD)、肺癌、气喘、结核病和其他呼吸系统疾病。这些诊断工具用于各种医疗保健场所，例如医院、临床实验室、医生办公室、参考实验室和其他最终使用者设施。

2025年春季，美国关税突然上调及其引发的贸易摩擦对医疗设备产业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战进一步加剧了形势，因为由于关税而更换供应商通常需要医疗设备重新认证，导致市场准入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司（The Business Research Company）新报告系列的一部分，该系列提供呼吸设备及器械（诊断）市场统计数据，例如全球市场规模、区域份额、竞争对手的市场份额、详细的呼吸设备及器械（诊断）细分市场、市场趋势和机会，以及您在呼吸设备及器械（诊断）行业取得成功所需的数据。本呼吸设备及器械（诊断）市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的一切观点。

我们预测未来五年该市场将成长9.8%，较先前预测略有下降0.4%。这一下降主要源自于美国与其他国家之间关税的影响。该影响可能透过对主要来自法国和加拿大的肺量计流量感测器和气体分析仪组件征收关税直接影响美国，并将增加肺功能测试的成本。此外，互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响也将更广泛地反映出来。

各种呼吸系统疾病的盛行率不断上升，增加了对用于诊断和治疗的诊断仪器和设备的需求，从而促进了全球呼吸设备和器械市场的成长。慢性阻塞性肺病(COPD) 等疾病在老年人中特别常见。 COPD 是阻塞型肺疾。例如，2024 年 7 月，澳洲政府机构澳洲健康与福利研究所报告称，2022 年死于 COPD 的人数将达到 7,691 人，即每 100,000 人口中有 29.6 人死亡，占所有死亡人数的 4.0%。因此，病例数的增加推动了对诊断仪器和设备的需求，刺激了呼吸设备和器械（诊断）市场的扩张。

预计人口老化将成为呼吸设备市场成长的驱动因素，尤其是在诊断领域。老化是指社会和人口中老年人口比例不断增加的人口结构变化。呼吸诊断设备和仪器在监测和管理老年人口的呼吸健康方面发挥关键作用，有助于早期发现和介入慢性阻塞性肺病 (COPD) 和睡眠呼吸中止症等疾病。截至2022年7月，联合国经济社会事务部预测，全球65岁及以上人口的比例将从2022年的10%上升到2050年的16%。因此，不断增长的老龄化人口将成为呼吸诊断设备和仪器市场扩张的催化剂。

呼吸设备和器材市场的公司正越来越多地投资于可携式和无线诊断工具。这一趋势的驱动力在于它们的易用性、成本效益、先进的功能以及与居家医疗环境的兼容性。与传统设备相比，配备创新技术的携带式呼吸设备正在引入市场，这些设备可以即时诊断呼吸频率和脉搏率等生命征象。例如，美国政府机构国家生物技术资讯中心在2024年5月强调，这些携带式非侵入式设备可立即提供结果，这对于患有慢性阻塞性肺病（COPD）和气喘等慢性呼吸系统疾病的患者至关重要。现场诊断可改善患者预后并提高医疗保健系统的效率。

呼吸诊断市场的主要企业正致力于开发先进的诊断技术，例如自动核酸纯化仪器和Applied Biosystems MagMAX Dx病毒/病原体核酸分离试剂盒，以提高病毒检测的准确性和速度。这些仪器和套件能够快速可靠地提取病毒遗传物质，以便进行准确的诊断测试。例如，2023年12月，美国生技公司赛默飞世尔科技宣布推出呼吸诊断测试的样品製备解决方案。赛默飞世尔科技的KingFisher Apex Dx可自动纯化多达24或96个DNA、RNA、蛋白质和细胞样本，确保呼吸测试的高品质结果。与Applied Biosystems MagMAX Dx病毒/病原体核酸分离试剂盒结合使用时，它可提供全面的体外诊断解决方案。该系统配备先进的数据管理和网路安全安全功能，支援从样品製备到即时PCR分析的顺畅工作流程，使其适用于研究和诊断目的。

2022年1月，美国医疗设备製造商ICU Medical Inc.以23.5亿美元收购了史密斯医疗公司。此次策略性收购涵盖了史密斯医疗的注射器、门诊输液设备、血管通路解决方案以及重症监护产品。此次收购预计将增强ICU Medical的输液治疗产品系列，使其能够服务新兴的临床护理市场。史密斯医疗公司总部位于美国，致力于开发、製造和销售呼吸诊断设备等医疗产品。

呼吸诊断市场的主要参与者包括 ResMed Inc.、Medtronic plc、Masimo Corporation、Fisher & Paykel Healthcare Limited、Koninklijke Philips NV、Smiths Medical、GE Healthcare、Chart Industries Inc.、Philips Healthcare、Becton Dickinson and Company (BD)、Abbott Laboratories、ThePat 至 Fisher Scientic Inc. Fisher. Fisher Scicire、Yia Co. KGaA、Getinge AB、Drager Medical GmbH、bioMerieux、Bio-Rad Laboratories Inc.、Cosmed Srl、Seegene Inc.、SDI Diagnostics、GlaxoSmithKline plc、Hillrom、Hamilton Medical AG、Medline Industries Inc、3M Company、Air Liquideline plc、Hillrom、Hamilton Medical AG、Medline Industries Inc、 工业 Corporation 和 O2 Concepts LLC。

2024年，亚太地区是呼吸器材及器材（诊断）市场最大的地区。北美是呼吸器材及器材（诊断）市场的第二大地区。呼吸设备及器材（诊断）市场报告涵盖亚太地区、西欧、东欧、北美、南美、中东和非洲。

呼吸设备和装置（诊断）市场报告涵盖的国家有澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国、美国、义大利、西班牙和加拿大

呼吸诊断设备市场包括肺计量计、睡眠多项生理检查、峰值流量计以及用于诊断呼吸系统疾病的监测设备（例如脉动式血氧监测仪系统、二氧化碳分析仪和气体分析仪）的销售。该市场的商品价值为出厂价，即商品製造商或生产者向其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接向最终客户销售的商品价值。该市场的商品价值还包括商品生产者销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球呼吸设备与器材（诊断）：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球呼吸诊断设备与设备市场：成长率分析
  • 全球呼吸诊断设备与设备市场表现：规模与成长，2019-2024
  • 全球呼吸诊断设备和设备市场预测：规模和成长，2024-2029年，2034年
  • 全球呼吸设备和设备（诊断）：总目标市场（TAM）

第六章 市场细分

  • 全球呼吸诊断设备市场：依产品、绩效及预测，2019-2024年、2024-2029年、2034年
  • 设备和装置
  • 检测方法和试剂
  • 全球呼吸诊断设备市场（按测试类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 传统诊断测试
  • 机械检查
  • 影像检查
  • 分子诊断测试
  • 全球呼吸诊断设备市场（按疾病类型、表现和预测），2019-2024 年、2024-2029 年、2034 年
  • 慢性阻塞性肺病
  • 肺癌
  • 气喘
  • 结核
  • 其他疾病
  • 全球呼吸诊断设备市场（按最终用户、绩效和预测），2019-2024 年、2024-2029 年、2034 年
  • 医院或临床实验室
  • 医生诊所
  • 参考实验室
  • 其他最终用户
  • 全球呼吸诊断设备和设备市场：按设备和设备（类型）、性能和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 肺计量计
  • 脉动式血氧监测仪系统
  • 峰值流量计
  • 二氧化碳测量仪
  • 呼吸压力监测器
  • 可携式人工呼吸器
  • 全球呼吸诊断设备和设备市场：按分析和试剂类型、性能和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 诊断试剂套件
  • 呼吸道感染疾病试剂
  • 血气分析试剂
  • 呼吸道病原体 PCR 检测

第七章 区域和国家分析

  • 全球呼吸诊断设备市场：按地区、绩效及预测，2019-2024年、2024-2029年、2034年
  • 全球呼吸诊断设备市场：依国家、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 呼吸设备和设备（诊断）市场：竞争格局
  • 呼吸设备和设备（诊断）市场：公司简介
    • ResMed Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • Masimo Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Fisher & Paykel Healthcare Limited Overview, Products and Services, Strategy and Financial Analysis
    • Koninklijke Philips NV Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Smiths Medical
  • GE Healthcare
  • Chart Industries Inc.
  • Philips Healthcare
  • Becton Dickinson and Company（BD）
  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • Teleflex Incorporated
  • Invacare Corporation
  • Vyaire Medical Inc.
  • Dragerwerk AG & Co. KGaA
  • Getinge AB
  • Drager Medical GmbH
  • bioMerieux
  • Bio-Rad Laboratories Inc-Bio-Rad Laboratories Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年呼吸诊断设备：提供新机会的国家
  • 2029年呼吸诊断设备：细分市场将带来新机会
  • 2029年呼吸诊断设备市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r32754u

Respiratory diagnostic devices and equipment are used to diagnose respiratory conditions like asthma, cystic fibrosis, and chronic obstructive pulmonary disease. These devices help measure lung function and oxygen levels, assisting healthcare providers in assessing and managing respiratory health.

The primary products within the respiratory devices and equipment (diagnostic) market encompass instruments and devices, as well as assays and reagents. These respiratory instruments and devices are critical for the diagnosis of various respiratory disorders. Diagnostic tests are available in various types, including traditional diagnostic tests, mechanical tests, imaging tests, and molecular diagnostic tests, all of which are employed in diagnosing conditions such as chronic obstructive pulmonary disease (COPD), lung cancer, asthma, tuberculosis, and other respiratory diseases. These diagnostic tools are used in a variety of healthcare settings, including hospital and clinical laboratories, physician offices, reference laboratories, and other end-user facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The respiratory devices and equipment (diagnostic) market research report is one of a series of new reports from The Business Research Company that provides respiratory devices and equipment (diagnostic) market statistics, including respiratory devices and equipment (diagnostic) industry global market size, regional shares, competitors with a respiratory devices and equipment (diagnostic) market share, detailed respiratory devices and equipment (diagnostic) market segments, market trends and opportunities, and any further data you may need to thrive in the respiratory devices and equipment (diagnostic) industry. This respiratory devices and equipment (diagnostic) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The respiratory devices and equipment (diagnostic) market size has grown strongly in recent years. It will grow from $7.81 billion in 2024 to $8.36 billion in 2025 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to chronic respiratory diseases, aging population, smoking and environmental factors, technological advancements.

The respiratory devices and equipment (diagnostic) market size is expected to see strong growth in the next few years. It will grow to $12.13 billion in 2029 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to respiratory infections, telemedicine and remote monitoring, personalized medicine, ai and machine learning. Major trends in the forecast period include pulmonary function testing (pft), home respiratory monitoring, telemedicine integration, smoking cessation aids.

The forecast of 9.8% growth over the next five years reflects a modest reduction of 0.4% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on spirometry flow sensors and gas analyzer components, primarily sourced from France and Canada, increasing costs for lung function testing.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising prevalence of various respiratory diseases has contributed to the growth of the global respiratory devices and equipment market by increasing the demand for diagnostic devices and equipment for diagnosis and treatment. Conditions such as chronic obstructive pulmonary disease (COPD) are particularly common among the elderly. COPD is an obstructive lung disease that causes long-term breathing difficulties. For example, in July 2024, the Australian Institute of Health and Welfare, a government agency based in Australia, reported that in 2022, COPD was responsible for 7,691 deaths, or 29.6 per 100,000 people, accounting for 4.0% of all fatalities. As a result, the growing number of such cases has driven the demand for diagnostic devices and equipment, thus fueling the expansion of the respiratory devices and equipment (diagnostic) market.

The aging population is anticipated to be a key driver of growth in the respiratory devices and equipment market, especially in the diagnostic segment. An aging population refers to the demographic shift characterized by a rising proportion of elderly individuals within a society or population. Respiratory diagnostic devices and equipment play a pivotal role in monitoring and managing respiratory health for the aging population, aiding in early detection and intervention for conditions like COPD and sleep apnea. As of July 2022, the United Nations Department of Economic and Social Affairs has projected that the proportion of the world's population aged 65 and older is expected to increase from 10% in 2022 to 16% by 2050. Consequently, the growing aging population acts as a catalyst for the expansion of the respiratory devices and equipment (diagnostic) market.

Companies in the respiratory devices and equipment market are increasingly investing in portable and wireless diagnostic tools. This trend is driven by the ease of use, cost-effectiveness, advanced features, and their suitability for home care settings. Innovative, technology-enabled portable respiratory devices are being introduced to the market, offering immediate diagnosis of vital signs such as respiratory and pulse rates, in contrast to traditional devices. For example, in May 2024, the National Center for Biotechnology Information, a U.S.-based government agency, highlighted that this portable, noninvasive device provides immediate results, making it crucial for patients with chronic respiratory conditions like COPD and asthma. By offering on-site diagnostics, it improves patient outcomes and enhances the efficiency of healthcare systems.

Leading companies in the respiratory devices and equipment (diagnostic) market are focusing on developing advanced diagnostic technologies, such as automated nucleic acid purification instruments and the Applied Biosystems MagMAX Dx Viral/Pathogen NA Isolation Kit, to improve the accuracy and speed of viral detection. These instruments and kits enable the quick and reliable extraction of viral genetic material for precise diagnostic testing. For instance, in December 2023, Thermo Fisher Scientific Inc., a U.S.-based biotechnology company, introduced Sample Preparation Solutions for Respiratory Diagnostic Testing. The Thermo Scientific KingFisher Apex Dx automates the purification of up to 24 or 96 samples of DNA, RNA, proteins, or cells, ensuring high-quality results for respiratory tests. It integrates with the Applied Biosystems MagMAX Dx Viral/Pathogen NA Isolation Kit, providing a comprehensive solution for in vitro diagnostics. With advanced data management and cybersecurity features, this system supports smooth workflows from sample preparation to real-time PCR analysis, making it suitable for both research and diagnostic purposes.

In January 2022, ICU Medical Inc., a U.S.-based medical device company, completed the acquisition of Smiths Medical for $2.35 billion. This strategic acquisition included Smiths Medical's syringe and ambulatory infusion devices, vascular access solutions, and vital care products. It was expected to strengthen ICU Medical's infusion therapy product portfolio and extend its offerings into emerging clinical care markets. Smiths Medical is a U.S.-based firm that develops, manufactures, and sells medical products, including diagnostic respiratory devices and equipment.

Major companies operating in the respiratory devices and equipment (diagnostic) market include ResMed Inc., Medtronic plc, Masimo Corporation, Fisher & Paykel Healthcare Limited, Koninklijke Philips N.V., Smiths Medical, GE Healthcare, Chart Industries Inc., Philips Healthcare, Becton Dickinson and Company (BD), Abbott Laboratories, Thermo Fisher Scientific Inc., Teleflex Incorporated, Invacare Corporation, Vyaire Medical Inc., Dragerwerk AG & Co. KGaA, Getinge AB, Drager Medical GmbH, bioMerieux, Bio-Rad Laboratories Inc - Bio-Rad Laboratories Inc., Cosmed S.r.l., Seegene Inc., SDI Diagnostics, GlaxoSmithKline plc, Hillrom, Hamilton Medical AG, Medline Industries Inc., 3M Company, Air Liquide, Allied Healthcare Products Inc., Armstrong Medical, Bio-Med Devices Inc., Breas Medical AB, CAIRE Inc., DeVilbiss Healthcare, Nihon Kohden Corporation, O2 Concepts LLC

Asia-Pacific was the largest region in the respiratory devices and equipment (diagnostic) market in 2024. North America was the second largest region in the respiratory devices and equipment (diagnostic) market. The regions covered in the respiratory devices and equipment (diagnostic) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the respiratory devices and equipment (diagnostic) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada

The respiratory devices and equipment (diagnostic) market consist of sales of spirometer, polysomnographs, and peak flow meters and monitoring devices are pulse oximeters, capnography, and gas analyzers that are used for diagnosis of respiratory diseases. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Respiratory Devices And Equipment (Diagnostic) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on respiratory devices and equipment (diagnostic) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for respiratory devices and equipment (diagnostic) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The respiratory devices and equipment (diagnostic) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Instruments And Devices; Assays And Reagents
  • 2) By Test Type: Traditional Diagnostic Tests; Mechanical Tests; Imaging Tests; Molecular Diagnostic Tests
  • 3) By Disease Type: Chronic Obstructive Pulmonary Disease; Lung Cancer; Asthma; Tuberculosis; Other Diseases
  • 4) By End User: Hospital/Clinical Laboratories; Physician Offices; Reference Laboratories; Other End Users
  • Subsegments:
  • 1) By Instruments And Devices: Spirometers; Pulse Oximeters; Peak Flow Meters; Capnographs; Respiratory Pressure Monitors; Portable Ventilators
  • 2) By Assays And Reagents: Diagnostic Kits; Reagents For Respiratory Infections; Blood Gas Analysis Reagents; PCR Assays For Respiratory Pathogens
  • Companies Mentioned: ResMed Inc.; Medtronic plc; Masimo Corporation; Fisher & Paykel Healthcare Limited; Koninklijke Philips N.V.; Smiths Medical; GE Healthcare; Chart Industries Inc.; Philips Healthcare; Becton Dickinson and Company (BD); Abbott Laboratories; Thermo Fisher Scientific Inc.; Teleflex Incorporated; Invacare Corporation; Vyaire Medical Inc.; Dragerwerk AG & Co. KGaA; Getinge AB; Drager Medical GmbH; bioMerieux; Bio-Rad Laboratories Inc - Bio-Rad Laboratories Inc.; Cosmed S.r.l.; Seegene Inc.; SDI Diagnostics; GlaxoSmithKline plc; Hillrom; Hamilton Medical AG; Medline Industries Inc.; 3M Company; Air Liquide; Allied Healthcare Products Inc.; Armstrong Medical; Bio-Med Devices Inc.; Breas Medical AB; CAIRE Inc.; DeVilbiss Healthcare; Nihon Kohden Corporation; O2 Concepts LLC
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Respiratory Devices And Equipment (Diagnostic) Market Characteristics

3. Respiratory Devices And Equipment (Diagnostic) Market Trends And Strategies

4. Respiratory Devices And Equipment (Diagnostic) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Respiratory Devices And Equipment (Diagnostic) Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Respiratory Devices And Equipment (Diagnostic) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Respiratory Devices And Equipment (Diagnostic) Market Growth Rate Analysis
  • 5.4. Global Respiratory Devices And Equipment (Diagnostic) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Respiratory Devices And Equipment (Diagnostic) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Respiratory Devices And Equipment (Diagnostic) Total Addressable Market (TAM)

6. Respiratory Devices And Equipment (Diagnostic) Market Segmentation

  • 6.1. Global Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Instruments And Devices
  • Assays And Reagents
  • 6.2. Global Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Traditional Diagnostic Tests
  • Mechanical Tests
  • Imaging Tests
  • Molecular Diagnostic Tests
  • 6.3. Global Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Chronic Obstructive Pulmonary Disease
  • Lung Cancer
  • Asthma
  • Tuberculosis
  • Other Diseases
  • 6.4. Global Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital Or Clinical Laboratories
  • Physician Offices
  • Reference Laboratories
  • Other End Users
  • 6.5. Global Respiratory Devices And Equipment (Diagnostic) Market, Sub-Segmentation Of Instruments And Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Spirometers
  • Pulse Oximeters
  • Peak Flow Meters
  • Capnographs
  • Respiratory Pressure Monitors
  • Portable Ventilators
  • 6.6. Global Respiratory Devices And Equipment (Diagnostic) Market, Sub-Segmentation Of Assays And Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnostic Kits
  • Reagents For Respiratory Infections
  • Blood Gas Analysis Reagents
  • PCR Assays For Respiratory Pathogens

7. Respiratory Devices And Equipment (Diagnostic) Market Regional And Country Analysis

  • 7.1. Global Respiratory Devices And Equipment (Diagnostic) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Respiratory Devices And Equipment (Diagnostic) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Respiratory Devices And Equipment (Diagnostic) Market

  • 8.1. Asia-Pacific Respiratory Devices And Equipment (Diagnostic) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Respiratory Devices And Equipment (Diagnostic) Market

  • 9.1. China Respiratory Devices And Equipment (Diagnostic) Market Overview
  • 9.2. China Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Respiratory Devices And Equipment (Diagnostic) Market

  • 10.1. India Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Respiratory Devices And Equipment (Diagnostic) Market

  • 11.1. Japan Respiratory Devices And Equipment (Diagnostic) Market Overview
  • 11.2. Japan Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Respiratory Devices And Equipment (Diagnostic) Market

  • 12.1. Australia Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Respiratory Devices And Equipment (Diagnostic) Market

  • 13.1. Indonesia Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Respiratory Devices And Equipment (Diagnostic) Market

  • 14.1. South Korea Respiratory Devices And Equipment (Diagnostic) Market Overview
  • 14.2. South Korea Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Respiratory Devices And Equipment (Diagnostic) Market

  • 15.1. Western Europe Respiratory Devices And Equipment (Diagnostic) Market Overview
  • 15.2. Western Europe Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Respiratory Devices And Equipment (Diagnostic) Market

  • 16.1. UK Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Respiratory Devices And Equipment (Diagnostic) Market

  • 17.1. Germany Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Respiratory Devices And Equipment (Diagnostic) Market

  • 18.1. France Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Respiratory Devices And Equipment (Diagnostic) Market

  • 19.1. Italy Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Respiratory Devices And Equipment (Diagnostic) Market

  • 20.1. Spain Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Respiratory Devices And Equipment (Diagnostic) Market

  • 21.1. Eastern Europe Respiratory Devices And Equipment (Diagnostic) Market Overview
  • 21.2. Eastern Europe Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Respiratory Devices And Equipment (Diagnostic) Market

  • 22.1. Russia Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Respiratory Devices And Equipment (Diagnostic) Market

  • 23.1. North America Respiratory Devices And Equipment (Diagnostic) Market Overview
  • 23.2. North America Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Respiratory Devices And Equipment (Diagnostic) Market

  • 24.1. USA Respiratory Devices And Equipment (Diagnostic) Market Overview
  • 24.2. USA Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Respiratory Devices And Equipment (Diagnostic) Market

  • 25.1. Canada Respiratory Devices And Equipment (Diagnostic) Market Overview
  • 25.2. Canada Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Respiratory Devices And Equipment (Diagnostic) Market

  • 26.1. South America Respiratory Devices And Equipment (Diagnostic) Market Overview
  • 26.2. South America Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Respiratory Devices And Equipment (Diagnostic) Market

  • 27.1. Brazil Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Respiratory Devices And Equipment (Diagnostic) Market

  • 28.1. Middle East Respiratory Devices And Equipment (Diagnostic) Market Overview
  • 28.2. Middle East Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Respiratory Devices And Equipment (Diagnostic) Market

  • 29.1. Africa Respiratory Devices And Equipment (Diagnostic) Market Overview
  • 29.2. Africa Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Respiratory Devices And Equipment (Diagnostic) Market Competitive Landscape And Company Profiles

  • 30.1. Respiratory Devices And Equipment (Diagnostic) Market Competitive Landscape
  • 30.2. Respiratory Devices And Equipment (Diagnostic) Market Company Profiles
    • 30.2.1. ResMed Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Masimo Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Fisher & Paykel Healthcare Limited Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis

31. Respiratory Devices And Equipment (Diagnostic) Market Other Major And Innovative Companies

  • 31.1. Smiths Medical
  • 31.2. GE Healthcare
  • 31.3. Chart Industries Inc.
  • 31.4. Philips Healthcare
  • 31.5. Becton Dickinson and Company (BD)
  • 31.6. Abbott Laboratories
  • 31.7. Thermo Fisher Scientific Inc.
  • 31.8. Teleflex Incorporated
  • 31.9. Invacare Corporation
  • 31.10. Vyaire Medical Inc.
  • 31.11. Dragerwerk AG & Co. KGaA
  • 31.12. Getinge AB
  • 31.13. Drager Medical GmbH
  • 31.14. bioMerieux
  • 31.15. Bio-Rad Laboratories Inc - Bio-Rad Laboratories Inc.

32. Global Respiratory Devices And Equipment (Diagnostic) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Respiratory Devices And Equipment (Diagnostic) Market

34. Recent Developments In The Respiratory Devices And Equipment (Diagnostic) Market

35. Respiratory Devices And Equipment (Diagnostic) Market High Potential Countries, Segments and Strategies

  • 35.1 Respiratory Devices And Equipment (Diagnostic) Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Respiratory Devices And Equipment (Diagnostic) Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Respiratory Devices And Equipment (Diagnostic) Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer